These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 3480379)

  • 41. Assessment of major carcinogenic tobacco-specific N-nitrosamines in Thai cigarettes.
    Brunnemann KD; Mitacek EJ; Liu Y; Limsila T; Suttajit M
    Cancer Detect Prev; 1996; 20(2):114-21. PubMed ID: 8706036
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tobacco alkaloids and tobacco-specific nitrosamines in dust from homes of smokeless tobacco users, active smokers, and nontobacco users.
    Whitehead TP; Havel C; Metayer C; Benowitz NL; Jacob P
    Chem Res Toxicol; 2015 May; 28(5):1007-14. PubMed ID: 25794360
    [TBL] [Abstract][Full Text] [Related]  

  • 43. N-nitrosodiethanolamine: analysis, formation in tobacco products and carcinogenicity in Syrian golden hamsters.
    Hoffmann D; Brunnemann KD; Rivenson A; Hecht SS
    IARC Sci Publ; 1982; (41):299-308. PubMed ID: 7141536
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Volatile N-nitrosamines in snuff and chewing tobacco on the Swedish market.
    Osterdahl BG; Slorach SA
    Food Chem Toxicol; 1983 Dec; 21(6):759-62. PubMed ID: 6686581
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of herpes simplex virus replication by tobacco extracts.
    Hirsch JM; Svennerholm B; Vahlne A
    Cancer Res; 1984 May; 44(5):1991-7. PubMed ID: 6324994
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutagenicity and carcinogenicity of masheri, a pyrolysed tobacco product, and its content of tobacco-specific nitrosamines.
    Bhide SV; Kulkarni J; Nair UJ; Spiegelhalder B; Preussmann R
    IARC Sci Publ; 1987; (84):460-2. PubMed ID: 3679422
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of smokeless tobacco among adults--United States, 1991.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Apr; 42(14):263-6. PubMed ID: 8459796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification and analysis of a nicotine-derived N-nitrosamino acid and other nitrosamino acids in tobacco.
    Djordjevic MV; Brunnemann KD; Hoffmann D
    Carcinogenesis; 1989 Sep; 10(9):1725-31. PubMed ID: 2766465
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tobacco-specific nitrosamines in the saliva of Inuit snuff dippers in the Northwest Territories of Canada.
    Brunnemann KD; Hornby AP; Stich HF
    Cancer Lett; 1987 Oct; 37(1):7-16. PubMed ID: 3664451
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chemical studies on tobacco smoke LXVIII. Analysis of volatile and tobacco-specific nitrosamines in tobacco products.
    Hoffmann D; Adams JD; Piade JJ; Hecht SS
    IARC Sci Publ; 1980; (31):507-16. PubMed ID: 7228275
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epidemiologic perspectives on smokeless tobacco marketing and population harm.
    Tomar SL
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S387-97. PubMed ID: 18021914
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk for oral cancer from smokeless tobacco.
    Janbaz KH; Qadir MI; Basser HT; Bokhari TH; Ahmad B
    Contemp Oncol (Pozn); 2014; 18(3):160-4. PubMed ID: 25520574
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comprehensive chemical characterization of Rapé tobacco products: Nicotine, un-ionized nicotine, tobacco-specific N'-nitrosamines, polycyclic aromatic hydrocarbons, and flavor constituents.
    Stanfill SB; Oliveira da Silva AL; Lisko JG; Lawler TS; Kuklenyik P; Tyx RE; Peuchen EH; Richter P; Watson CH
    Food Chem Toxicol; 2015 Aug; 82():50-8. PubMed ID: 25934468
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tobacco-specific N-nitrosamines in the saliva of habitual male snuff dippers.
    Osterdahl BG; Slorach S
    Food Addit Contam; 1988; 5(4):581-6. PubMed ID: 3192010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemical studies on tobacco smoke. XLII. Nitrosonornicotine: presence in tobacco, formation and carcinogenicity.
    Hoffmann D; Hecht SS; Ornaf RM; Wynder EL; Tso TC
    IARC Sci Publ (1971); 1976; (14):307-20. PubMed ID: 12092
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Medical consequences of polonium in snuff].
    Samuelsson C
    Lakartidningen; 1989 Jun; 86(24):2290-1. PubMed ID: 2747357
    [No Abstract]   [Full Text] [Related]  

  • 57. National Institutes of Health consensus statement. Health implications of smokeless tobacco use. NIH Consensus Development Panel.
    Biomed Pharmacother; 1988; 42(2):93-8. PubMed ID: 3048429
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemical constituents and bioactivity of tobacco smoke.
    Hoffmann D; Wynder EL
    IARC Sci Publ; 1986; (74):145-65. PubMed ID: 3623665
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutagenic activity in smokeless tobacco products sold in the USA.
    Guttenplan JB
    Carcinogenesis; 1987 May; 8(5):741-3. PubMed ID: 3581433
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of 23 polycyclic aromatic hydrocarbons in smokeless tobacco by gas chromatography-mass spectrometry.
    Stepanov I; Villalta PW; Knezevich A; Jensen J; Hatsukami D; Hecht SS
    Chem Res Toxicol; 2010 Jan; 23(1):66-73. PubMed ID: 19860436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.